Dobutamine Induced Eosinophilic Myocarditis and Right Heart Failure Requiring Emergent Biventricular Assist Device Implantation
Authors:
- Neil P. LewisNLNeil P. Lewis
- Gundars J. KatlapsGKGundars J. Katlaps
- Mohammed A. QuaderMQMohammed A. Quader
- Keyur B. ShahKSKeyur B. Shah
- Anit K. MankadAMAnit K. Mankad
- 1 March 2015
- journal article
- case report
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 61 (2) , 213-215
Abstract
Dobutamine is a rare and unrecognized cause of eosinophilic myocarditis (EM). It is even more unique for it to cause significant clinical deterioration. Patients with end stage cardiomyopathy have very little cardiac reserve and dobutamine induced myocarditis may cause enough harm to require urgent mechanical circulatory support. We describe a man with dilated cardiomyopathy that developed accelerated clinical deterioration from dobutamine induced EM. He had a predominance of right heart failure, requiring an urgent biventricular assist device and acutely responded to withdrawal of dobutamine.Keywords
This publication has 3 references indexed in Scilit:
- Characteristics of Patients With Advanced Heart Failure Having Eosinophilic Infiltration of the Myocardium in the Recent EraInternational Heart Journal, 2013
- Eosinophilic myocarditis in patients awaiting heart transplantation*Critical Care Medicine, 2004
- EosinophiliaNew England Journal of Medicine, 1998